NasdaqCM:ASTHHealthcare
A Look At Astrana Health's Valuation After CMS Medicare Advantage Payment Proposal
The recent proposal from the Centers for Medicare & Medicaid Services for 2027 Medicare Advantage payment updates, which signals only modest payment growth, has become a key focus for Astrana Health (ASTH) shareholders after triggering a sharp price reaction.
See our latest analysis for Astrana Health.
The CMS proposal has come on top of what has already been a weak stretch for Astrana Health, with a 7 day share price return of a 17.54% decline, a 90 day share price return of a 30.84% decline...